Publications by authors named "Eric Leifer"

Claim this Profile
F
Framework for Analytical Validation of DHT-Based Actigraphy and Signal Measures in HF Trials: The VALIDATE-HF Program.
Orhun Kose, Aymen Sahal, Guang K Zhang, Elite Possik, Mona Fiuzat, Eric Leifer

JACC Heart Fail· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Primary Results From Blood and Marrow Transplant Clinical Trials Network 1702: Clinical Transplant-Related Long-Term Outcomes of Alternative Donor Allogeneic Transplantation.
Stephanie J Lee, Brent Logan, Mary M Horowitz, Jason G Dehn, Joseph Pidala, Eric Leifer

J Clin Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: BMT CTN 1702 Trial.
Jason G Dehn, Brent Logan, Stephanie J Lee, Bronwen E Shaw, Steven Devine, Eric Leifer

Transplant Cell Ther· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sensitivity Analyses for Missing in Repeatedly Measured Outcome Data.
James F Troendle, Aparajita Sur, Eric S Leifer, Tiffany Powell-Wiley

Stat Med· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of posttransplant cyclophosphamide-based GVHD prophylaxis in patients 70 years and older: an update from BMT CTN 1703.
Sameem Abedin, Michael J Martens, Javier Bolaños-Meade, Monzr M Al Malki, Qinghua Lian, Eric Leifer

Blood Adv· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hierarchical Analysis of Composite Time-to-Event End Points in Heart Failure Clinical Trials Using Time in Clinical State.
Eric S Leifer, James F Troendle, Mitchell A Psotka, Vandana Sachdev

Circ Heart Fail· July 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Viral and Immune Factors Associated With COVID-19 Outcome in the C3PO Trial of Convalescent Plasma.
Clara Di Germanio, Erika G Marques de Menezes, Robert Clevenger, Ian Rines, Valerie L Durkalski-Mauldin, Eric Leifer

J Infect Dis· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sequential monitoring of time-to-event safety endpoints in clinical trials.
Michael J Martens, Qinghua Lian, Nancy L Geller, Eric S Leifer, Brent R Logan

Clin Trials· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.
Gabrielle Meyers, Mehdi Hamadani, Michael Martens, Haris Ali, Patrice Chevallier, Eric Leifer

Bone Marrow Transplant· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved Patient-Reported Outcomes With Post-Transplant Cyclophosphamide: A Quality-of-Life Evaluation and 2-Year Outcomes of BMT CTN 1703.
Shernan G Holtan, Javier Bolaños-Meade, Monzr M Al Malki, Juan Wu, Carrie L Kitko, Eric Leifer

J Clin Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.
Adetola A Kassim, Mark C Walters, Mary Eapen, Madoc Smith, Brent R Logan, Eric Leifer

NEJM Evid· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A comparison of computational algorithms for the Bayesian analysis of clinical trials.
Ziming Chen, Jeffrey S Berger, Lana A Castellucci, Michael Farkouh, Ewan C Goligher, Eric S Leifer

Clin Trials· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparison of Bayesian and frequentist monitoring boundaries motivated by the Multiplatform Randomized Clinical Trial.
Jungnam Joo, Eric S Leifer, Michael A Proschan, James F Troendle, Harmony R Reynolds

Clin Trials· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of sodium-glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial.
Mikhail N Kosiborod, Sheryl L Windsor, Orly Vardeny, Jeffrey S Berger, Harmony R Reynolds, Eric S Leifer

Lancet Diabetes Endocrinol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sodium-glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials.
Claire Vale, Peter J Godolphin, David Fisher, Peter W Horby, Mikhail N Kosiborod, Eric Leifer

Lancet Diabetes Endocrinol· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term survival after unrelated donor marrow transplantation for aplastic anaemia after optimized conditioning regimen: a retrospective multicentre cohort study.
Mary Eapen, Joseph H Antin, Jakub Tolar, Sally Arai, Mitchell E Horwitz, Eric Leifer

EClinicalMedicine· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The statistical design and analysis of pandemic platform trials: Implications for the future.
Christopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, Scott Berry, Erica Brittain, Eric Leifer

J Clin Transl Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Erratum: The statistical design and analysis of pandemic platform trials: Implications for the future - CORRIGENDUM.
Christopher J Lindsell, Matthew Shotwell, Kevin J Anstrom, Scott Berry, Erica Brittain, Eric Leifer

J Clin Transl Sci· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Access to Allogeneic Cell Transplantation Based on Donor Search Prognosis: An Interventional Trial.
Jason G Dehn, Brent Logan, Bronwen E Shaw, Steven Devine, Stefan O Ciurea, Eric Leifer

medRxiv· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence to Exercise in Adults With Heart Failure.
Windy W Alonso, Steven J Keteyian, Eric S Leifer, Dalane W Kitzman, Vandana Sachdev

J Cardiopulm Rehabil Prev· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Use of win time for ordered composite endpoints in clinical trials.
James F Troendle, Eric S Leifer, Song Yang, Neal Jeffries, Dong-Yun Kim

Stat Med· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of Life.
Yonatan Y Greenstein, Kinsley Hubel, Joshua Froess, Stephen R Wisniewski, Vidya Venugopal, Eric Leifer

Chest· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic Impact of Repeated NT-proBNP Measurements in Patients With Heart Failure With Reduced Ejection Fraction.
Michael A Fuery, Eric S Leifer, Marc D Samsky, Sounok Sen, Christopher M O'Connor

JACC Heart Fail· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Heparin Dose Intensity and Organ Support-Free Days in Patients Hospitalized for COVID-19.
Lucas C Godoy, Matthew D Neal, Ewan C Goligher, Mary Cushman, Brett L Houston, Eric Leifer

JACC Adv· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Anti-CD3/CD7 immunoconjugate (T-Guard) for severe, steroid-refractory GVHD: final report of BMT CTN 2002.
Gabrielle Meyers, Mehdi Hamadani, Michael Martens, Haris Ali, Patrice Chevallier, Eric Leifer

Bone Marrow Transplant· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis